Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.870
+0.230 (14.02%)
At close: Oct 21, 2025, 4:00 PM EDT
1.870
0.00 (0.00%)
After-hours: Oct 21, 2025, 5:32 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $114.8 million as of October 21, 2025. Its market cap has decreased by -83.02% in one year.
Market Cap
114.80M
Enterprise Value
-85.86M
1-Year Change
-83.02%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $114.80M, a decrease of -84.44%. That is a compound annual growth rate of -29.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 100.68M | -87.44% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |